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Abstract:  
Background: The transient receptor potential vanilloid 1 (TRPV1) channel is critical for 
spinal afferent signalling of burning pain throughout the body. Such pain frequently 
originates from the esophagus, following acid reflux. The contribution of TRPV1 to spinal 
nociceptor signalling from the esophagus remains unclear. We aimed to identify the spinal 
afferent pathways that convey nociceptive signalling from the esophagus, specifically those 
sensitive to acid, and the extent to which TRPV1 contributes.  
Methods: Acid/pepsin (150mM HCl / 1mg ml-1 pepsin) or saline/pepsin was perfused into the 
esophageal lumen of anesthetised wild-type and TRPV1 null mice over 20 minutes, followed 
by atraumatic perfuse-fixation and removal of the cervical and thoracic spinal cord and dorsal 
root ganglia (DRG). To identify neurons responsive to esophageal perfusate, 
immunolabelling for neuronal activation marker phosphorylated extracellular receptor-
regulated kinase (pERK) was used. Labelling for calcitonin gene related peptide (CGRP) and 
isolectin B4 (IB4) was then used to characterize responsive neurons.  
Key Results: Esophageal acid/pepsin perfusion significantly increased the number of pERK-
immunoreactive (IR) neurons in the DRG and the cervical and thoracic spinal cord dorsal 
horn (DH) relative to saline/pepsin (DRG P<0.01; cervical DH P<0.05 and thoracic DH 
P<0.005). The number of pERK-IR neurons following acid perfusion was significantly 
attenuated in TRPV1 -/- mice (DH P<0.05 and DRG P<0.05). 
Conclusions and inferences: This study has identified populations of spinal afferent DRG 
neurons and DH neurons involved in signalling of noxious acid from the esophagus. There is 
a major contribution of TRPV1 to signalling within these pathways. 
 
Key words: pain, esophagus, TRPV1, spinal cord, and acid reflux. 
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Introduction: 
The sensation of heartburn is the main symptom of gastro-esophageal reflux disease (GERD). 
It is evoked initially by excitation of primary afferent endings in or below the squamous 
epithelium (1, 2). These afferent fibres then project to the spinal cord in the thoracic 
sympathetic nerves, or to the brain stem in the vagal nerves. It is considered that the spinal 
pathway is more exclusively concerned with pain transmission, whereas the vagal pathway is 
also responsible for non-noxious sensations and reflex integration (3-6). The neuronal cell 
bodies of spinal afferent fibres supplying the esophagus are widely distributed within cervical 
(C1-C6) and thoracic (T1-T13) dorsal root ganglia (DRG), with peak distribution localised to 
C1-C4 and T3-T8 DRG  (2, 7, 8). However, the neuronal circuits within the spinal cord 
receiving and processing esophageal sensory input remain to be clearly identified. It is 
assumed that esophageal spinal afferents terminate in the spinal cord within the superficial 
dorsal horn (DH). This is on the basis of in vivo electrophysiological recordings identifying 
DH neurons in the thoracic spinal cord activated by esophageal distension and intraluminal 
chemicals (9, 10). In the present study, we aimed to identify and localise the spinal afferent 
DRG neurons and the spinal cord DH neurons activated by acute exposure of the esophageal 
lumen to noxious acid. Neuronal activation was identified using immunohistochemical 
labelling of phosphorylated ERK1/2 (pERK), a marker of neuronal activation induced by 
peripheral noxious stimuli (11, 12). ERKs are mitogen-activated protein kinases (MAPKs) 
activated by membrane depolarization and calcium influx, with their activation known to be 
one of the intracellular signalling pathways involved in neuronal plasticity of persistent pain 
hypersensitivity (13), particularly in the sensitization of nociceptors related to peripheral 
inflammation (14). Spinal cord sensitization is implicated in facilitating the chronic nature of 
esophageal pain associated with both GERD and oesophagitis (9, 15-18). In particular, 
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sensitization of thoracic spinal cord circuits are suggested to mediate the symptoms of non-
cardiac chest pain associated with acid reflux (10, 19, 20). 
 
The activation of nociceptive spinal afferents by acid is mediated via specialized nociceptive 
transducer receptor/ion channel complexes on peripheral terminals. There are a number of 
candidates as transducers, including acid sensing ion channels (ASICs) and transient receptor 
potential (TRP) channels. These are potential targets in the clinical setting of hypersensitive 
esophagus, resistant to traditional pharmacological management by gastric acid suppression 
(21).  Thus, treatment could be aimed at manipulating afferent ending sensitivity, by 
specifically targeting spinal nociceptive signalling. Transient receptor potential ion channel 
vanilloid 1 (TRPV1) is a transducer protein generating depolarizing currents in response to 
noxious low pH stimuli (22, 23). TRPV1 is abundantly expressed by visceral afferent 
nociceptors and has a role in the pathophysiology of acid induced esophageal hypersensitivity 
(4, 24-27). However, recent clinical trials have shown that TRPV1 antagonists are ineffective 
in reducing esophageal pain following distension and acid exposure in both healthy 
volunteers and reflux disease patients. (28, 29).  Therefore, it remains unclear what role 
TRPV1 plays in nociceptive signalling within spinal afferent pathways induced by noxious 
esophageal acid. We used TRPV1 null (-/-) mice to determine the extent to which TRPV1 
channels mediate signalling of noxious esophageal acid exposure within spinal afferent 
pathways.   
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Materials and methods: 
Animal preparation: 
Experiments were performed in 22-25g female C57/BL6 mice (000664 JAX Mice, The 
Jackson Laboratory, Maine, USA) and TRPV1 null (-/-) mice (B6.129X1-Trpv1tm1Jul/J; 
003770 JAX Mice). The TRPV1 -/- mice were generated by target vector disruption of the 
encoding part of the fifth and all of the sixth putative transmembrane domains together with 
the pore-loop region and no gene product (mRNA or protein) is detected in DRG. (22) 
Genotyping confirmed the absence of TRPV1 encoding DNA sequences in these mice. All 
experiments were performed in accordance with the guidelines of the Animal Ethics 
Committees of the Institute for Medical and Veterinary Science and the University of 
Adelaide, Adelaide, Australia. 
 
Esophageal acid perfusion: 
Mice (N=4/experimental group) were fasted for 15 minutes, anesthetized with isoflurane (2% 
in oxygen), the right carotid artery cannulated and a perfusion tube (1 mm diameter) was 
secured 1 cm into the proximal esophagus at the level of the larynx. A drainage tube (2 mm 
diameter) was then inserted into the distal esophagus via the stomach, secured 0.5 cm above 
the level of the diaphragm. Rectal temperature was measured throughout, and environment 
heating adjusted to maintain normal core temperature (37oC). After a 30 minute stabilization 
period to ensure neuronal activation observed in the DRG and spinal cord was due to 
esophageal perfusate rather than the surgery or esophageal distension, warm (37oC) 
saline/pepsin (1 mg ml-1) was perfused into the esophagus (0.5 ml/min). After 1 minute, this 
perfusion was changed either to a warm acid/pepsin solution (0.15 M HCl and 1 mg ml-1 
pepsin in saline) or continued. After 20 minutes mice were infused via the carotid artery with 
pentobarbitone (15 mg ml-1), the vena cava opened, then perfused with 20 ml warm 
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heparin/saline then 50 ml of ice-cold 4% paraformaldehyde (Sigma-Aldrich, MO, USA) via 
the carotid artery. The cervical (C1-C6) and thoracic (T1-T13) spinal cord segments with 
attached dorsal root ganglia (DRG) were then removed and post-fixed overnight at 4oC. 
Tissue was cryoprotected in 30% sucrose/0.1M phosphate buffer (Sigma-Aldrich, MO, USA) 
overnight followed by overnight incubation at 4oC in equal volumes of 30% sucrose/0.1M PB 
and optimal cutting temperature compound (OCT; Tissue-Tek, Sakura Finetek, CA, USA) 
before snap freezing in OCT.  
 
Immunohistochemistry: 
Frozen sections (15m) were cut and processed for immunohistochemistry. Non-specific 
binding of secondary antibodies was blocked with 5% normal chicken serum diluted in 0.2% 
Triton-TX 100 (Sigma-Aldrich, MO, USA) in 0.1M phosphate buffered saline. Tissue 
sections were incubated with primary antisera, diluted in 0.2% Triton-TX/PBS, overnight at 
room temperature. A monoclonal rabbit anti-Phospho-p44/42 MAPK (Erk1/2) 
(Thr202/Tyr204) (pERK 1:200; #4370 Cell Signalling Technology, MA, USA) was used to 
identify activated neurons. Spinal cord sections were co-labelled with a goat anti-calcitonin 
gene-related peptide (CGRP 1:200; Abcam) (30) and biotin-conjugated isolectin B4 (IB4 
1:200; Life Technologies, CA, USA). Sections were then incubated for 1 hour at room 
temperature with secondary antibodies chicken anti-rabbit AlexaFluor®594, chicken anti-
goat AlexaFluor®488 and Streptavidin-488 (1:200; Molecular probes, Life Technologies, 
CA, USA). Negative controls were prepared as above with the primary antibody omitted. 
Images were obtained using an epifluorescent microscope (Olympus BX51) and confocal 
scanning microscope (Leica SP5). The optimal working dilution of each antibody was 
determined empirically. Omission of the primary or secondary antibody resulted in the 
absence of labelling. The protocol used for double-labelling immunohistochemistry did not 
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affect the distribution or the intensity of each label compared to corresponding single 
labelling pattern. Additionally, the secondary antibodies used did not cross react with 
unmatched primaries, showing that the secondary antibodies bind specifically to the targeted 
primary antibodies.  
 
Statistical analysis of pERK-immunoreactivity (pERK-IR): 
Neurons immunoreactive for pERK were counted down the microscope (Olympus BX51 X20 
lens) from 30 randomly selected sections (greater than 50 m apart) of cervical spinal cord 
(spanning C1-C6), thoracic spinal cord (spanning T1-T13) and DRG. The mean number of 
pERK-IR neurons from each tissue type was then averaged across 4 mice/experimental 
group. The proportion of DRG neurons immunoreactive for both pERK/CGRP or pERK/IB4 
was quantified from 5 randomly selected DRG sections from wild-type mice exposed to 
esophageal acid/pepsin or saline/pepsin  (N=3).  Un-paired student t-tests were performed 
using GraphPad Prism software (GraphPad Software V 5.0, CA, USA) to determine 
differences in the average number of pERK-IR neurons/section in each tissue type between 
experimental groups. Significant differences between groups were considered at *P<0.05, 
**P<0.01 and ***P<0.005.  
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Results: 
TRPV1 wild-type (+/+) mice: 
Acid/pepsin perfusion of the mouse esophagus increased the number of pERK-IR neurons 
within the DH of the spinal cord (Fig. 1) and neurons within the DRG (Fig. 2). In the cervical 
DH, pERK-IR neurons were primarily localised to lamina I (LI) (Fig. 1A), which was clearly 
identified by CGRP-immunoreactivity (Fig. 1C). In contrast pERK-IR neurons were rarely 
localized to deeper lamina identified by IB4-labelling (Fig. 1A and 1D). In the thoracic spinal 
cord, pERK-IR neurons were abundant in LI (Fig. 2B and 2E), however, they were also 
present, albeit to a lesser extent, in deeper lamina II-V (Fig. 1B and F). Compared to 
saline/pepsin control experiments (Fig. 1G and 1H), the average number of pERK-IR neurons 
in the cervical (saline 5±2 vs. acid 63±17, P<0.05) and thoracic (saline 27±2 vs. acid 106±12, 
P<0.005) DH was significantly greater after acid exposure (Fig. 1I).  
 
Neurons immunoreactive for pERK were present in the DRG attached to cervical and 
thoracic regions of the spinal cord following esophageal acid exposure (Fig. 2). These 
neurons were immunoreactive for the peptide CGRP (84±2 %, Fig 2B) but none labelled for 
IB4 (Fig 2C). Mice perfused with saline/pepsin also displayed pERK-IR neurons in DRG 
(Fig 2D-F), however, in comparison to acid/pepsin perfused mice, fewer were CGRP-
immunoreactive (37±14%, Fig. 2E) and an additional population labeled for IB4 (22±10%, 
Fig. 2F). The average number of pERK-IR neurons across cervical and thoracic DRG was 
significantly increased after acid perfusion (saline: 14±2 vs. acid: 52±11; P<0.01, Fig. 2G). 
Taken together these data suggest an additional population of DRG neurons is activated upon 
noxious esophageal acid exposure to those activated by innocuous saline alone or esophageal 
distension due to perfusate.  
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TRPV1 knock-out (-/-) mice 
Similar experiments to those described above were also performed in TRPV1 -/- mice. 
Neurons immunoreactive for pERK were detected following esophageal acid/pepsin 
perfusion in TRPV1 -/- mice in the DH (Fig. 3A) and DRG (Fig. 3B).  The number of pERK-
IR neurons in DH was significantly greater (P<0.05) following acid/pepsin perfusion in the 
cervical (Fig. 3C) and thoracic (Fig. 3D) spinal cord compared to saline/pepsin perfused 
TRPV1 -/- mice (P<0.05). However, the average number of pERK-IR neurons following 
acid/pepsin perfusion was significantly lower (P<0.05) in TRPV1 -/- mice than that observed 
in TRPV1 +/+ mice (Fig. 3C and D). Thus the extent of DH neuron activation by esophageal 
acid was greatly reduced in mice lacking TRPV1. There was no difference in the average 
number of pERK-IR DH neurons in saline/pepsin perfused TRPV1 +/+ and TRPV1 -/- mice 
(Fig. 3C and D).  
 
In the DRG of TRPV1 -/- mice (Fig. 3B and 3E), acid/pepsin perfusion did not induce a 
significant increase (P>0.05) in the number of pERK-IR neurons compared to saline/pepsin 
perfusion. This is in direct contrast to results obtained from TRPV1+/+ mice, where 
acid/pepsin exposure did cause a significant increase over saline/pepsin exposure (Fig. 3E). 
Consequently, significantly fewer (P<0.05) pERK-IR neurons were present in the DRG of 
TRPV1 -/- mice after acid/pepsin perfusion compared to TRPV1 +/+ mice (Fig. 3E).  
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Discussion: 
We have shown that esophageal acid/pepsin exposure activates expression of pERK-
immunoreactivity in neurons of the spinal cord DH and DRG. We know from previous work 
that these neurons are involved in pain transmission. In TRPV1 knockouts we saw a 
reduction by approximately one half in the neural pERK activation by esophageal acid, 
compared with wild types. This was seen at both primary afferent and spinal cord level. This 
suggests that TRPV1 plays a significant role in peripheral activation of esophageal pain 
pathways. 
 
Spinal afferent endings in the proximal esophagus project into the cervical and upper thoracic 
spinal cord, whilst spinal afferent endings within the distal esophagus project into the thoracic 
spinal cord (2, 31). In this study, acid exposure activated greater numbers of DH neurons in 
the thoracic spinal cord compared with the cervical spinal cord. Responsive neurons in the 
cervical spinal cord were confined to the superficial DH, whereas those in the thoracic DH 
were also localised in deeper laminae. Lamina I of the superficial DH is the known projection 
zone for nociceptive afferent fibres and contains, in majority, central projection neurons that 
signal directly into various brain regions (brainstem, thalamus and parabrachial area) and 
excitatory interneurons (32, 33). The deeper DH laminae also contain central projection 
neurons, but greater numbers of excitatory and inhibitory interneurons (LII-III) as well as 
neurons with wide dynamic activation ranges (LV), which receive input from both 
nociceptive and non-nociceptive afferents and DH interneurons (33). Peripheral triggered 
ERK phosphorylation is found not only in first order DH neurons receiving direct synaptic 
input from afferent terminals, but also third or fourth order neurons activated indirectly via 
interneuronal circuits within the DH. The difference in the distribution of pERK-IR neurons 
we observed between the cervical and thoracic DH upon esophageal acid indicates that 
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noxious input from the esophagus into the cervical spinal cord is likely to undergo less 
intraspinal modulation and filtering before being relayed into brain regions than the noxious 
input into the thoracic spinal cord, which is more divergent (34).   
 
Correspondingly, in humans, perception of pain is more readily evoked from the proximal 
esophagus (35), although this may also happen because afferent endings in the proximal 
esophagus are relatively more sensitive.  In either case, this mechanism would support the 
role of proximal afferents as an alarm to signal impending aspiration of esophageal contents. 
In the thoracic DH, given the wide distribution of neurons responsive to noxious esophageal 
acid we describe here, afferent input may contribute to cross-sensitisation of thoracic spinal 
pathways receiving input from cardiac and respiratory organs (10, 31, 34). In agreement, 
functional studies show acute gastresophageal reflux enhances the excitatory responses of 
thoracic spinal neurons in deeper laminae of the DH to a noxious cardiac stimulus (36). It is 
an important caveat that we may have underestimated the activation of spinal pathways, as 
animals were anaesthetised in this study, so that the level of descending inhibitory control to 
the spinal cord may be more than in the normal state (37, 38).  
 
We found that the majority of DRG neurons responsive to esophageal acid were CGRP-IR, 
and not IB4 labelled. On the other hand those responsive to saline infusion (a non-noxious 
response to distension and/ or activation of mucosal afferents by flow) were less likely to be 
peptidergic and displayed IB4 labelling. This is another example of the specialization of 
sensory neural function being reflected in their chemical coding (39) 
 
In TRPV1 -/- mice we saw an approximate 50% reduction in the number of neurons activated 
by esophageal acid perfusion relative to wild-type mice. This reduction was evident at both 
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the primary afferent neuron and spinal cord level. This suggests that TRPV1 plays a 
significant role in activation of esophageal spinal pain pathways. In addition to the role of 
TRPV1 in spinal afferent signalling, TRPV1 channels are expressed by esophageal epithelia 
cells, where they mediate a localised release of excitatory peptides which contribute to the 
propagation of local inflammatory response to acid exposure (40, 41) and possibly 
influencing the neural responses we observed. TRPV1 is also expressed by populations of 
neurons in the spinal cord DH (42), where its role in mediating spinal nociceptive signalling 
remains to be established. Therefore, the involvement of TRPV1 could be due to influences at 
peripheral and central levels.   
 
TRPV1 -/- mice had similar numbers of DRG neurons activated by saline/pepsin and 
acid/pepsin perfusion of the esophagus. This suggests a peripheral mechanism by which 
TRPV1 is involved in acid activation of afferent endings and subsequently their cell bodies, 
which uses MAP kinase intracellular signalling. Activity-dependant phosphorylation of ERK 
in DRG neuron in response to noxious chemical stimulation of peripheral tissue or electrical 
stimulation of peripheral nerve ending has been previously reported (43). In particular, the 
TRPV1 agonist capsaicin evokes activation of somatic c-fibres and induces ERK 
phosphorylation in DRG neurons (43).  TRPV1 in the esophageal mucosa (44) could also 
contribute to this peripheral mechanism.  
 
Interestingly, esophageal acid perfusion led to increased numbers of pERK-IR neurons in the 
DH of TRPV1 -/- mice compared to saline perfused TRPV1 -/- mice, although neuron 
numbers were significantly less than in TRPV1 +/+ mice. This indicates that spinal afferent 
signalling into the DH still occurs in the absence of TRPV1, however to a lesser degree, and 
supports the involvement of additional mechanisms and acid sensitive channels in visceral 
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acid sensing (45). In particular, the family of acid sensing ion channels (ASICs) as well as the 
TRP family of ion channels are likely candidates to contribute to sensing of gastresophageal 
acid by spinal afferents (46).  
 
In addition to the spinal afferent pathway, there is substantial evidence that a subtype of vagal 
esophageal afferent fibres display nociceptive characteristics, including responsiveness to low 
pH and inflammatory mediators (5, 47, 48). These afferents have their cell bodies in the 
nodose and jugular ganglia, and terminate in the nucleus tractus solitarius along with non-
nociceptive vagal afferents. How pain is mediated from this point and how it interfaces with 
input from spinal afferents is not currently known. Acid sensing channels TRPV1, ASICs and 
ionotropic purinoceptors (P2X) have already been shown to contribute to vagal afferent 
ending acid detection and signalling from the esophagus into the brainstem (49-52). TRPV1 
contributes significantly within this system, with ASICs and P2X receptors having additional 
minimal roles that remain to be established (6, 51, 53). Our findings reinforce the importance 
of TRPV1 in esophageal sensation and the detection of noxious acidic stimuli.  
 
It should be noted that findings from human studies showing TRPV1 antagonist AZD1386 
does not prevent acid induced esophageal pain (28) contrast with our current findings. This 
disparity may indicate different roles for TRPV1 in esophageal nociceptive pathways 
between species. Furthermore, could also indicate insufficient blocking of TRPV1 by the 
antagonist at the concentrations administered (28). However, the latter is unlikely as the 
TRPV1 antagonist had an analgesic effect on the detection thresholds of esophageal pain to 
heat but not to electrical stimuli (28). This suggests a degree of receptor specific analgesic 
effect. These findings further implicate multiple signalling pathways mediating esophageal 
nociception in humans involving diverse proton-sensitive channels. 
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In conclusion, we have revealed the spinal afferent pathways from the esophagus signalling 
intraluminal noxious acid exposure. We have also shown that TRPV1 is a major, but not sole, 
contributor to signalling within this pathway, and is likely to be an important mediator of pain 
associated with GERD.  
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Common abbreviations: 
DRG: dorsal root ganglia 
DH: dorsal horn 
SDH: superficial dorsal horn 
TRPV1: transient receptor potential channel vanilloid 1 
L: laminae 
LI: lamina 1 
LII: lamina 2 
LIII: lamina 3 
LV: lamina 5 
C1-C6: cervical spinal cord levels 1-6 
T1-T12: thoracic spinal cord levels 1-12 
pERK: phosphorylated ERK1/2 
IR: immunoreactive 
CGRP: calcitonin gene related peptide 
IB4: isolectin B4 
+/+: wild-type. 
-/-: null mutant. 
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Figures: 
 
Figure 1. Activation of neurons within the spinal cord by intra-esophageal stimuli.      
(A) Representative image of the cervical spinal cord showing the distribution of pERK-IR 
neurons in Lamina I of the dorsal horn (DH) following intra-esophageal acid/pepsin.  
(B) Representative image of cervical and (B) thoracic spinal cord showing distribution of 
pERK-IR neurons in Laminae I-IV of the DH following intra-esophageal acid/pepsin.  
(C-F) Representative images showing the proximity of pERK-IR neurons to CGRP- and IB4-
positive afferent endings in the cervical and thoracic DH. 
 (G) Representative image showing a relative lack of pERK-IR neurons in the cervical DH 
following intra-esophageal saline/pepsin. 
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(H) Representative image showing a relative lack of pERK-IR neurons in the thoracic DH 
following intra-esophageal saline/pepsin perfusion. 
 (I) The average number of pERK-IR neurons in the cervical (*P<0.05) and thoracic 
(***P<0.005) DH was significantly greater following acid/pepsin esophageal perfusion 
compared with saline/pepsin perfusion (n=30 sections/spinal segment from N=4 mice). Scale 
bars = 20m. 
 
Figure 2. Dorsal root ganglion neurons are activation by intra-esophageal stimuli.      
(A-C) Representative images of pERK-IR DRG neurons after intra-esophageal acid/pepsin 
perfusion, many of which labelled for (B) CGRP, but not (C) IB4.  
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(D-F) Representative images of the few pERK-IR DRG neurons following intra-esophageal 
saline/pepsin perfusion Few of these neurons were (E) CGRP-IR, whilst a population were 
now (F) IB4-labelled. 
(G) The average number of pERK-IR DRG neurons following acid/pepsin esophageal 
perfusion was significantly greater than that observed in saline/pepsin perfused mice 
(**P<0.01 acid vs. saline, n=30 sections/spinal segment from N=4 mice). Scale bars = 20m. 
 
Figure 3. Effects of TRPV1 deletion on neuron activation.  
(A) Representative image showing a lack of acid/pepsin-evoked pERK-IR neurons in the 
thoracic DH of spinal cord taken from a TRPV1 -/- mouse. 
(B) Representative image of acid/pepsin-evoked pERK-IR DRG neurons from a TRPV1 -/-  
mouse.   
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(C-E) Average number of pERK-IR neurons in the (C) cervical DH,  (D) thoracic DH and 
(E) DRG following saline/pepsin or acid/pepsin esophageal perfusion in TRPV1 +/+ (white 
bars) and TRPV1 -/- (grey bars) mice. (C) In the cervical spinal cord acid exposure 
significantly increased the number of pERK-IR neurons compared to saline/pepsin exposure 
in TRPV1 +/+ mice (*P<0.05). This effect was significantly attenuated in TRPV1 -/- mice 
(*P<0.05).  (D) Similarly, in the thoracic spinal cord acid/pepsin exposure significantly 
increased the number of pERK-IR neurons compared with saline/pepsin exposure in TRPV1 
+/+ mice (***P<0.005), which was significantly reversed in TRPV1 -/- mice (*P<0.05). (E) 
Esophageal acid/pepsin perfusion did not significantly change the number of pERK-IR DRG 
neurons compared with saline/pepsin in TRPV1 -/- mice, which was significantly less than in 
TRPV1 +/+ mice (*P<0.05). n=30 sections/spinal segment from N=4 mice. Scale bars = 
20m. 
